#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	18022	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2654	836.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1733	1733	C	1101	C,T,G,A	1097,1,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	18022	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2654	836.0	0	HET	.	.	.	C1450T,G	.	1450	1450	C	1999	1999	C	1222	C,T,G	905,315,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	18022	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2654	836.0	0	HET	.	.	.	C451T,G	.	451	451	C	1000	1000	C	1156	C,T,G	587,568,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30446	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4052	937.2	0	.	n	.	0	T695C	SNP	695	695	T	1223	1223	C	1119	C,T	1117,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30446	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4052	937.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1865	1865	A	1221	A,C,T,G	1217,2,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30446	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4052	937.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2499	2499	C	1102	C,A,G	1099,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30446	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4052	937.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2573	2573	A	1028	A,T	1027,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30446	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4052	937.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3125	3125	C	1047	C	1047	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30446	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4052	937.2	0	HET	.	.	.	A412G,C	.	412	412	A	940	940	A	1151	A,G,C	616,517,1	.	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2600	folP	855	855	100.0	folP.l15.c4.ctg.1	2108	153.9	1	SNP	p	R229S	0	.	.	685	687	CGC	1245	1247	CGC	257;260;259	C;G;C	257;260;259	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6260	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3904	200.1	1	SNP	p	S91F	0	.	.	271	273	TCC	810	812	TCC	226;226;227	T,A;C;C	225,1;226;227	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6260	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3904	200.1	1	SNP	p	D95G	0	.	.	283	285	GAC	822	824	GAC	246;247;245	G;A;C	246;247;245	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6260	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3904	200.1	1	SNP	p	D95N	0	.	.	283	285	GAC	822	824	GAC	246;247;245	G;A;C	246;247;245	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	2312	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1957	147.5	1	SNP	p	G45D	1	.	.	133	135	GAC	821	823	GAC	270;273;281	G;A,G,C;C	270;271,1,1;281	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1232	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1483	103.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5932	parC	2304	2304	99.83	parC.l6.c4.ctg.1	3449	214.6	1	SNP	p	D86N	0	.	.	256	258	GAC	830	832	GAC	266;266;265	G;A;C	266;266;265	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5932	parC	2304	2304	99.83	parC.l6.c4.ctg.1	3449	214.6	1	SNP	p	S88P	0	.	.	262	264	TCC	836	838	TCC	266;267;265	T;C,A;C	266;266,1;265	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5078	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3326	190.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1839	1841	GGC	271;267;266	G,C;G,T;C	269,2;266,1;266	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	539	4700	penA	1749	1749	99.89	penA.l6.c4.ctg.1	2927	200.4	0	.	p	.	0	F315L	NONSYN	943	945	TTC	1536	1538	TTA	285;283;283	T;T;A	285;283;283	.	.
penA.9.001	penA.9.001	1	1	539	4700	penA	1749	1749	99.89	penA.l6.c4.ctg.1	2927	200.4	0	.	p	.	0	G547S	NONSYN	1639	1641	GGC	2232	2234	AGC	234;236;237	A,C;G,A;C,G	233,1;235,1;236,1	.	.
penA.9.001	penA.9.001	1	1	539	4700	penA	1749	1749	99.89	penA.l6.c4.ctg.1	2927	200.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1524	1526	GCA	278;279;277	G;C;A	278;279;277	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4700	penA	1749	1749	99.89	penA.l6.c4.ctg.1	2927	200.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1527	1529	ATC	277;280;280	A;T;C	277;280;280	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4700	penA	1749	1749	99.89	penA.l6.c4.ctg.1	2927	200.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1539	1541	GTG	281;280;279	G;T,G;G	281;279,1;279	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4700	penA	1749	1749	99.89	penA.l6.c4.ctg.1	2927	200.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1539	1541	GTG	281;280;279	G;T,G;G	281;279,1;279	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4700	penA	1749	1749	99.89	penA.l6.c4.ctg.1	2927	200.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2043	2045	ACC	266;262;265	A,T;C,A;C	265,1;261,1;265	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4700	penA	1749	1749	99.89	penA.l6.c4.ctg.1	2927	200.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2097	2099	GCG	258;260;259	G;C;G,C	258;260;258,1	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4700	penA	1749	1749	99.89	penA.l6.c4.ctg.1	2927	200.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2097	2099	GCG	258;260;259	G;C;G,C	258;260;258,1	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4700	penA	1749	1749	99.89	penA.l6.c4.ctg.1	2927	200.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2220	2222	GGC	230;231;232	G,T;G;C	229,1;231;232	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4700	penA	1749	1749	99.89	penA.l6.c4.ctg.1	2927	200.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2229	2231	GGC	233;232;235	G,A,C;G;C	231,1,1;232;235	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4700	penA	1749	1749	99.89	penA.l6.c4.ctg.1	2927	200.4	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2247	2249	CTG	256;264;266	C;T,C;G	256;262,2;266	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	6236	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	3789	205.6	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1974	1976	CCG	238;240;240	C;C;G	238;240;240	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2914	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2268	160.1	0	.	p	.	0	S22G	NONSYN	64	66	AGC	590	592	GGC	217;214;215	G;G,C;C	217;213,1;215	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2914	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2268	160.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	772	772	C	240	C	240	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3274	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1810	221.8	0	.	p	.	0	D41G	NONSYN	121	123	GAC	548	550	GGC	293;289;289	G,T;G;C,A	292,1;289;288,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3274	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1810	221.8	1	SNP	p	G120K	1	G120K	NONSYN	358	360	GGC	785	787	AAG	275;273;273	A,C;A,C;G	274,1;272,1;273	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3274	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1810	221.8	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	854	856	CAA	301;306;304	C,A,T;A;A	299,1,1;306;304	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3274	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1810	221.8	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1061	1063	GAT	294;293;294	G;A;T	294;293;294	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3274	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1810	221.8	0	.	p	.	0	H213G	NONSYN	637	639	CAT	1064	1066	GGT	291;292;292	G;G;T	291;292;292	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3274	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1810	221.8	0	.	p	.	0	Q214H	NONSYN	640	642	CAA	1067	1069	CAT	291;291;291	C;A;T,G,A	291;291;289,1,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3274	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1810	221.8	0	.	p	.	0	V215T	NONSYN	643	645	GTT	1070	1072	ACT	289;289;291	A;C,T;T	289;288,1;291	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3274	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1810	221.8	0	.	p	.	0	I218M	NONSYN	652	654	ATC	1079	1081	ATG	282;285;278	A;T,G,A;G	282;283,1,1;278	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3274	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1810	221.8	0	.	p	.	0	R257T	NONSYN	769	771	AGG	1196	1198	ACG	246;243;247	A,T;C;G,T	245,1;243;246,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3274	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1810	221.8	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1202	1204	GTT	244;245;241	G,A;T,A;T	243,1;244,1;241	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3274	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1810	221.8	0	.	p	.	0	D294N	NONSYN	880	882	GAT	1307	1309	AAT	269;271;271	A;A;T	269;271;271	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3274	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1810	221.8	1	SNP	p	A121D	1	.	.	361	363	GAC	788	790	GAC	277;279;283	G,C;A;C	276,1;279;283	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3274	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1810	221.8	1	SNP	p	D121N	0	.	.	361	363	GAC	788	790	GAC	277;279;283	G,C;A;C	276,1;279;283	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11452	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5463	261.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1674	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1445	143.8	1	SNP	p	V57M	1	.	.	169	171	ATG	797	799	ATG	298;299;295	A,G;T;G	296,2;299;295	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
